Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 494

1.

[Heart failure with thiazolidinedione treatment: what do we know today?].

Erdmann E.

Dtsch Med Wochenschr. 2009 Jan;134(4):154-8. doi: 10.1055/s-0028-1123973. Epub 2009 Jan 15. Review. German.

PMID:
19148858
2.

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association.

Circulation. 2003 Dec 9;108(23):2941-8. Review. No abstract available.

3.

Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.

Patel RR.

Cardiol Rev. 2009 May-Jun;17(3):132-5. doi: 10.1097/CRD.0b013e31819faab2. Review.

PMID:
19384087
4.

Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

Buckingham RE, Hanna A.

Diabetes Obes Metab. 2008 Apr;10(4):312-28. doi: 10.1111/j.1463-1326.2006.00700.x. Review.

PMID:
18333890
5.

Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.

Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB.

Pharmacotherapy. 2006 Feb;26(2):168-81. Review.

PMID:
16466323
6.

Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update.

Sarafidis PA.

Fundam Clin Pharmacol. 2008 Jun;22(3):247-64. doi: 10.1111/j.1472-8206.2008.00568.x. Epub 2008 Apr 15. Review.

PMID:
18422634
7.

Thiazolidinedione-induced edema in patients with heart failure.

Stroup JS.

Am J Health Syst Pharm. 2007 Dec 1;64(23):2426-30; author reply 2430. No abstract available.

PMID:
18029947
8.

Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure.

Erdmann E, Wilcox RG.

Eur Heart J. 2008 Jan;29(1):12-20. doi: 10.1093/eurheartj/ehm529. Review.

PMID:
18167366
9.

Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.

Granberry MC, Hawkins JB, Franks AM.

Am J Health Syst Pharm. 2007 May 1;64(9):931-6. Review.

PMID:
17468147
10.

[Heart failure while taking glitazones--what do we know today?].

Halbritter R.

Dtsch Med Wochenschr. 2009 Jul;134(28-29):1488; author reply 1488. doi: 10.1055/s-0029-1225308. Epub 2009 Jul 1. German. No abstract available.

PMID:
19572255
11.

Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Khanderia U, Pop-Busui R, Eagle KA.

Ann Pharmacother. 2008 Oct;42(10):1466-74. doi: 10.1345/aph.1K666. Epub 2008 Sep 2. Review.

PMID:
18698014
12.

Cardiovascular risk and TZD: safe therapy for the elderly?

Burt R, Townsend S, Armor B.

Consult Pharm. 2009 May;24(5):392-4.

PMID:
19555148
13.

The safety of rosiglitazone in the treatment of type 2 diabetes.

Singh S, Loke YK.

Expert Opin Drug Saf. 2008 Sep;7(5):579-85. doi: 10.1517/14740338.7.5.579 . Review.

PMID:
18759710
14.

[Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].

De Flines J, Scheen AJ.

Rev Med Suisse. 2007 Aug 29;3(122):1876, 1878-83. Review. French.

15.

Thiazolidinediones in patients with diabetes mellitus and heart failure : implications of emerging data.

Macfarlane DP, Fisher M.

Am J Cardiovasc Drugs. 2006;6(5):297-304. Review.

PMID:
17083264
16.

The role of glitazones in management of type 2 diabetes. A dream or a nightmare?

Lindberg M, Astrup A.

Obes Rev. 2007 Sep;8(5):381-4.

PMID:
17716295
17.

The "glitazones": rosiglitazone and pioglitazone.

Papoushek C.

J Obstet Gynaecol Can. 2003 Oct;25(10):853-7. Review. Erratum in: J Obstet Gynaecol Can. 2003 Nov;25(11):907.

PMID:
14532954
18.

The rough road for rosiglitazone.

Goldfine AB.

Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):113-7. doi: 10.1097/MED.0b013e3282f8b483. Review.

PMID:
18316944
19.

Do thiazolidinediones cause heart failure? A critical review.

Tang WH.

Cleve Clin J Med. 2006 Apr;73(4):390-7. Review. Erratum in: Cleve Clin J Med. 2006 Jun;73(6):588.

PMID:
16610400
20.

The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality.

Stafylas PC, Sarafidis PA, Lasaridis AN.

Int J Cardiol. 2009 Jan 24;131(3):298-304. doi: 10.1016/j.ijcard.2008.06.005. Epub 2008 Aug 5. Review.

PMID:
18684530

Supplemental Content

Support Center